This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Amgen Inc.. Active years: 2005.
Company Filing History:
Years Active: 2005
Title: Simon Van Der Plas: Innovator in Cancer Treatment
Introduction
Simon Van Der Plas is a notable inventor based in Kanata, Canada. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for cancer treatment. His innovative work has led to the creation of a patent that addresses critical medical needs.
Latest Patents
Simon holds a patent for "Substituted pyrimidinyl derivatives and methods of use." This invention encompasses compounds, analogs, prodrugs, and pharmaceutically acceptable salts. It also includes pharmaceutical compositions, uses, and methods for the prophylaxis and treatment of cancer. This patent highlights his commitment to advancing medical science and improving patient outcomes.
Career Highlights
Simon is currently employed at Amgen Inc., a leading biotechnology company. His role at Amgen allows him to work on cutting-edge research and development projects. With a focus on innovative solutions, he contributes to the company's mission of transforming the lives of patients.
Collaborations
Throughout his career, Simon has collaborated with esteemed colleagues, including Jean-Christophe P Harmange and John Laird Buchanan. These partnerships have fostered a collaborative environment that enhances the quality and impact of their research.
Conclusion
Simon Van Der Plas is a dedicated inventor whose work in cancer treatment exemplifies innovation in the pharmaceutical industry. His contributions through patents and collaborations continue to make a significant impact on healthcare.